BT
REGN icon

Banque Transatlantique’s Regeneron Pharmaceuticals REGN Stock Holding History

Banque Transatlantique’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159K Hold
254
– – ﹤0.01% 299
2026
Q1 		$196K Hold
254
– – ﹤0.01% 253
2025
Q4 		$196K Hold
254
– – ﹤0.01% 122
2025
Q3 		$143K Sell
254
-50
-16% -$28.3K ﹤0.01% 132
2025
Q2 		$160K Sell
304
-50
-14% -$27.9K ﹤0.01% 120
2025
Q1 		$225K Sell
354
-1,246
-78% -$857K 0.01% 112
2024
Q4 		$1.13M Buy
+1,600
New +$1.34M 0.03% 79

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Banque Transatlantique's REGN Position: Q2 2026 in Review

Banque Transatlantique held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 254 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #299.

Banque Transatlantique first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.13M in Q4 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Banque Transatlantique held 254 shares of Regeneron Pharmaceuticals worth $159K as of Q2 2026.
  • Banque Transatlantique left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Banque Transatlantique's portfolio in Q2 2026, its #299 holding.
  • Banque Transatlantique first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Regeneron Pharmaceuticals position peaked at $1.13M in Q4 2024.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.